← All startups
Kymera Therapeutics
Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
Team25
NameLocationLinksContact
Brian Adams
Chief Legal Officer
—
—
Bruce Booth
Co-Founder
—
—
Bruce Jacobs
Chief Financial Officer
—
—
Jeremy Chadwick
Chief Operating Officer
—
—
Nello Mainolfi
Founder
—
—
Noah Goodman
Chief Business Officer
—
—
Aimee Mishkin
Vice President
—
—
Karen Weisbach
VP
—
—
Matthew Henson
Vice President
—
—
Gorjan Hrustanovic
Director
—
—
Joanna Horobin
Director
—
—
John Maraganore
Director
—
—
Leigh Morgan
Director
—
—
Pamela L. Esposito
Director
—
—
Antonio Sica
Scientific Advisor
—
—
David Frank
Scientific Advisor
—
—
David Spiegel
Scientific Advisor
—
—
Elena Ridloff
Board Member
—
—
Jared Gollob
Executive Advisor
—
—
Jean-Laurent Casanova
Scientific Advisor
—
—
Jeff Albers
Board Member
—
—
Lea Florentino
Executive Business Partner To The CEO
—
—
Nick Keen
Scientific Advisor
—
—
Robert Terkeltaub
Scientific Advisor
—
—
Steven A. Carr
Scientific Advisor
—
—